Plunkett Research, Ltd.

Plunkett Research, Ltd. is a leading publisher of business and industry research. Our core focus is on analysis of industry trends, technologies and markets. Our unique business model and research methodology enables us to deliver accurate, timely information that will help you develop business strategy, find “points of pain,” make business contacts, determine market scope and consider investment opportunities. Many of our reports cover the most exciting, cutting-edge industries, and are packaged in a way that shows inter-industry synergies and opportunities. Good examples of this approach include our “Games, Apps & Social Media Industry” report, as well as our “Wireless, Wi-Fi, RFID and Cellular Industry” report.
Our research covers all major industry sectors. Our products are complete business resources, enabling professionals to access trends, statistics and companies in the world’s principal industries in a concise, easy to use package. In addition, Plunkett Research reports provide profiles of industry-leading companies (public and private, U.S. and non-U.S.), a database of industry contacts, associations and executives, and industry glossaries. Plunkett Research Products are particularly designed to be used by investors, consultants, marketing and product development executives and professionals involved in business development and international trade. Established in 1985, Plunkett’s client list includes 10,000 leading corporations, universities and government agencies worldwide.
Plunkett Research, Ltd.
View Sample
from this Publisher


Adobe Acrobat
required
 

List of reports from Plunkett Research, Ltd.

1  2  3  4    6    8  9  10  
Amedisys Inc (AMED: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/3/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Amedisys Inc) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
MEDNAX Inc (MD: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/3/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (MEDNAX Inc) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Gentiva Health Services Inc (GTIV: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/3/2014 | published by: Plunkett Research, Ltd.
... GTIV: NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Gentiva Health Services Inc) includes growth forecast for its primary industry to the ...  |  read more...
USD 1,795
Chemed Corporation (CHE: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/3/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Chemed Corporation) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
DaVita Healthcare Partners Inc (DVA: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/3/2014 | published by: Plunkett Research, Ltd.
... DVA: NYS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (DaVita Healthcare Partners Inc) includes growth forecast for its primary industry to the ...  |  read more...
USD 1,795
Quest Diagnostics Inc (DGX: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/3/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Quest Diagnostics Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Magellan Health Inc (MGLN: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/3/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Magellan Health Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Team Health Holdings Inc (TMH: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/3/2014 | published by: Plunkett Research, Ltd.
... TMH: NYS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Team Health Holdings Inc) includes growth forecast for its primary industry to the ...  |  read more...
USD 1,795
Regeneron Pharmaceuticals Inc (REGN: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/30/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Regeneron Pharmaceuticals Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Alexion Pharmaceuticals Inc (ALXN: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/30/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Alexion Pharmaceuticals Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Cubist Pharmaceuticals Inc (CBST: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/30/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Cubist Pharmaceuticals Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Vertex Pharmaceuticals Inc (VRTX: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/30/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Vertex Pharmaceuticals Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
United Therapeutics Corp (UTHR: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/30/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (United Therapeutics Corp) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Salix Pharmaceuticals (SLXP: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/30/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Salix Pharmaceuticals) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Medicines Co (The) (MDCO: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/30/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Medicines Co (The)) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Biogen IDEC Inc (BIIB: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Biogen IDEC Inc) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Celgene Corp (CELG: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Celgene Corp) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Allergan Inc (AGN: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Allergan Inc) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Hospira Inc (HSP: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Hospira Inc) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Actavis plc (ACT: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Actavis plc) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Mylan Inc (MYL: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Mylan Inc) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Perrigo Co (PRGO: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Perrigo Co) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Endo Health Solutions Inc (ENDP: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
... ENDP: NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Endo Health Solutions Inc) includes growth forecast for its primary industry to the ...  |  read more...
USD 1,795
Amgen Inc (AMGN: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/28/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Amgen Inc) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Bristol-Myers Squibb Co (BMY: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/28/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Bristol-Myers Squibb Co) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
1  2  3  4    6    8  9  10  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!